University of Cambridge > Talks.cam > Cambridge Society for the Application of Research (CSAR) > CSAR lecture: Development of a combined digital and biomarker test for Bipolar Disorder.

CSAR lecture: Development of a combined digital and biomarker test for Bipolar Disorder.

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact John Cook.

Currently the diagnosis of Bipolar Disorder (BD) and Major Depression (MDD) is based on the subjective reporting of symptoms which are evaluated through clinical interviews. Unfortunately, around 40% of BD patients are initially misdiagnosed as MDD and the average time until a correct diagnosis is achieved is 7.5 – 12 years.

To improve the correct diagnosis of BD, we have developed a two-stage diagnostic approach combining an online questionnaire, which assesses symptoms and demographic patient characteristics, in conjunction with a biomarker test using mass spectrometry (MS) on self-collected dried blood spots.

I will also report on findings from a 6- and 12-month follow-up questionnaire and the development of Censeo, a digital psychiatric assessment platform, which was developed by the Bahn lab in collaboration with Psyomics Ltd. The Censeo platform has now been implemented in several NHS trusts.

More details are here and you can book tickets for in-person attendance or find the Zoom link on Bookwhen .

This talk is part of the Cambridge Society for the Application of Research (CSAR) series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity